Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 2281 AL 2295

Emergence of exosomal miRNAs as a diagnostic biomarker for Alzheimer's disease

Van Giau V, An SS.

J Neurol Sci. 2016 Jan 15;360:141-52. doi: 10.1016/j.jns.2015.12.005. Epub 2015 Dec 4.

Meta-analysis of apolipoprotein E levels in the cerebrospinal fluid of patients with Alzheimer's disease

Talwar P, Sinha J, Grover S, Agarwal R, Kushwaha S, Srivastava MV, Kukreti R.

J Neurol Sci. 2016 Jan 15;360:179-87. doi: 10.1016/j.jns.2015.12.004. Epub 2015 Dec 3.

A review of cognitive impairment and differential diagnosis in idiopathic normal pressure hydrocephalus

Picascia M, Zangaglia R, Bernini S, Minafra B, Sinforiani E, Pacchetti C.

Funct Neurol. 2015 Oct-Dec;30(4):217-28. doi: 10.11138/fneur/2015.30.4.217.

Alzheimer disease, inflammation, and novel inflammatory marker: resistin

Kizilarslanoğlu MC, Kara Ö, Yeşil Y, Kuyumcu ME, Öztürk ZA, Cankurtaran M, Rahatli S, Pakaştiçali N, Çinar E, Halil MG, Sener B, Cankurtaran ES, Arioğul S.

Turk J Med Sci. 2015;45(5):1040-6.

Potential genetic biomarkers in the early diagnosis of Alzheimer disease: APOE and BIN1

Kaya G, Gündüz E, Acar M, Hatipoğlu ÖF, Acar B, Ilhan A, Gündüz M.

Turk J Med Sci. 2015;45(5):1058-72.

Plasma 8-isoPGF2α and serum melatonin levels in patients with minimal cognitive impairment and Alzheimer disease

Sirin FB, Kumbul Doğuç D, Vural H, Eren I, Inanli I, Sütçü R, Delibaş N.

Turk J Med Sci. 2015;45(5):1073-7. doi: 10.3906/sag-1406-134.

A Turkish 3-center study evaluation of serum folic acid and vitamin B12 levels in Alzheimer disease

Ulusu NN, Yilmaz G, Erbayraktar Z, Evlice AT, Aras S, Yener G, Avci A.

Turk J Med Sci. 2015;45(5):1159-66. doi: 10.3906/sag-1406-136.

Proteomics as an innovative tool to investigate frontotemporal disorders

Agresta AM, De Palma A, Bardoni A, Salvini R, Iadarola P, Mauri PL.

Proteomics Clin Appl. 2016 Apr;10(4):457-69. doi: 10.1002/prca.201500090. Epub 2015 Dec 10.

Neuropsychological predictors of conversion from mild cognitive impairment to Alzheimer's disease

Gainotti G, Quaranta D, Vita MG, Marra C.

J Alzheimers Dis. 2014;38(3):481-95. doi: 10.3233/JAD-130881.

Searching for disease-modifying drugs in AD: can we combine neuropsychological tools with biological markers?

Caraci F, Castellano S, Salomone S, Drago F, Bosco P, Di Nuovo S.

CNS Neurol Disord Drug Targets. 2014 Feb;13(1):173-86. doi: 10.2174/18715273113129990103.

Proteomics approaches to understand linkage between Alzheimer's disease and type 2 diabetes mellitus

Mirza Z, Ali A, Ashraf GM, Kamal MA, Abuzenadah AM, Choudhary AG, Damanhouri GA, Sheikh IA.

CNS Neurol Disord Drug Targets. 2014 Mar;13(2):213-25. doi: 10.2174/18715273113126660144.

Meta-analysis of serum non-ceruloplasmin copper in Alzheimer's disease

Squitti R, Simonelli I, Ventriglia M, Siotto M, Pasqualetti P, Rembach A, Doecke J, Bush AI.

J Alzheimers Dis. 2014;38(4):809-22. doi: 10.3233/JAD-131247.

Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers

Shen L, Thompson PM, Potkin SG, Bertram L, Farrer LA, Foroud TM, Green RC, Hu X, Huentelman MJ, Kim S, Kauwe JS, Li Q, Liu E, Macciardi F, Moore JH, Munsie L, Nho K, Ramanan VK, Risacher SL, Stone DJ, Swaminathan S, Toga AW, Weiner MW, Saykin AJ; Alzheimer’s Disease Neuroimaging Initiative.

Brain Imaging Behav. 2014 Jun;8(2):183-207. doi: 10.1007/s11682-013-9262-z.

Candidate blood proteome markers of Alzheimer's disease onset and progression: a systematic review and replication study

Kiddle SJ, Sattlecker M, Proitsi P, Simmons A, Westman E, Bazenet C, Nelson SK, Williams S, Hodges A, Johnston C, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Newhouse S, Lovestone S, Dobson RJ.

J Alzheimers Dis. 2014;38(3):515-31. doi: 10.3233/JAD-130380.

Vascular pathophysiology of Alzheimer's disease

Laske C, Stellos K.

Curr Alzheimer Res. 2014 Jan;11(1):1-3. doi: 10.2174/1567205010666131120101608.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias